Medidata Solutions (MDSO) Stock Price, News & Analysis

Company Overview

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.

Key Stats

• Today's Range: $92.21 to $92.26
• 50-Day Range: $91.79 to $92.25
• 52-Week Range: $60.10 to $98.60
• Volume: 7.30 million shs
• Average Volume: 1.24 million shs
• Market Capitalization: $5.76 billion
• P/E Ratio: 96.06
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDSO Stock Analysis - Frequently Asked Questions

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.31. The company's revenue for the quarter was up 15.8% compared to the same quarter last year.

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medidata Solutions investors own include Meta Platforms (META), NVIDIA (NVDA), Applied Materials (AMAT), Salesforce (CRM), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY) and Allergan (AGN).

Company Calendar

• Last Earnings: 7/22/2019
• Today: 4/24/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Prepackaged Software
• Sub-Industry: Health Care Technology
• Current Symbol: NASDAQ:MDSO
• CIK: 1453814
• Web: www.mdsol.com
• Phone: 212-918-1800
• Fax: N/A
• Employees: 1,998
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.96
• Trailing P/E Ratio: 96.06
• Forward P/E Ratio: 118.23
• P/E Growth: 6.95
• Net Income: $51.92 million
• Net Margins: 6.43%
• Pretax Margin: N/A
• Return on Equity: 8.64%
• Return on Assets: 5.73%

Debt

• Debt-to-Equity Ratio: 0.27
• Current Ratio: 2.56
• Quick Ratio: 2.56

Sales & Book Value

• Annual Sales: $635.70 million
• Price / Sales: 9.06
• Cash Flow: $1.69 per share
• Price / Cash Flow: 54.55
• Book Value: $10.32 per share
• Price / Book: 8.94

Miscellaneous

• Outstanding Shares: 62,460,000
• Free Float: N/A
• Market Cap: $5.76 billion
• Optionable: Optionable
• Beta: 1.22